Revelation Partners

Doug Fisher is a physician-investor (MD, Wharton MBA) and former CBO at Sera Prognostics, offering diagnostic development expertise while focusing on liquidity solutions and working with the Peter Michael Foundation.

Eric Shiozaki’s background as a structural biologist (PhD in Molecular Biology, Princeton) combined with cross-stage investing in early biotech, late private and secondaries gives him panoramic biopharma and device insight.

As Partner and Head of Business Origination, Fred Lee uses deep knowledge of capital structures—gained from venture debt, investment banking, and secondary/growth equity—to source and structure complex healthcare liquidity solutions.

Jonathan Au is a GP-led secondaries specialist in healthcare leveraging Goldman Sachs’ $45B Vintage Strategies and Brown biology background, structuring continuation vehicles and sourcing proprietary deals with 25+ buyout firms.

Liz Staley joined Revelation Partners in 2021 and has provided the firm with compliance program services since 2014 through prior roles at Leerink Capital Partners and Silicon Valley Bank. She has over 25 years of financial services experience, including more than 20 years in compliance, with earlier positions as Senior Compliance Officer at Hermes Fund Managers, Compliance Officer and Fund Administrator at Summit Partners, and Portfolio Assistant at Eaton Vance Management. She holds a BS in Business Administration from Emmanuel College and completed the Investment Adviser Certified Compliance Professional program.

Mike Boggs co-founded a $1.5B+ platform focused exclusively on healthcare secondaries, acting as a financing catalyst by pairing customized secondary solutions with leading new primary rounds.

Financial executive specializing in alternative investments, private valuations and SEC compliance; currently CFO of Altos Ventures and previously CFO/CCO of NewView Capital and CFO of the SharesPost 100 Fund.

Venture Advisory Network member; Managing Partner at Revelation Partners.

Rob Rein focuses on healthcare affordability and access, sourcing liquidity solutions for PE/VC firms; rapidly promoted from VP to principal, he helped invest over $100 million at Wells Fargo.

Chris Bayliss joined Revelation Partners in 2024, where he focuses on sourcing opportunities, conducting diligence, and leading transaction execution. He previously worked as a Vice President at SoftBank, contributing to its healthcare technology investments, and earlier held roles as an Analyst at Marcato Capital Management and on Barclays' Natural Resources M&A team. He holds a BSE in Civil Engineering and a BS in Economics from Duke University.

Colleen Hochberger joined Revelation Partners in 2020, where she handles firmwide marketing, investor relations, and office operations. Earlier in her career she launched a beverage brand distributed in California, worked as Executive Assistant to the CEO at Phaidon Press, and contributed as an editor at Artspace. She holds a BA in Art History from Skidmore College.

Garrett Brown joined Revelation Partners in 2022, where he works on transaction execution and diligence. He previously was a consultant at Bluestar BioAdvisors focused on strategy and market assessments for biopharma and medical device companies, served as Operations Lead at MARGIN (a medical supply purchasing platform), and conducted digital healthcare investment due diligence at Hikma Ventures. He holds a BS in Applied Mathematics with a minor in Entrepreneurship and Innovation from Columbia University's School of Engineering and a BA in Chemistry from Bard College.

Jordan Bloom joined Revelation Partners in 2026, where she focuses on transaction execution and diligence. She previously worked on the secondaries team at Carlyle AlpInvest handling diligence and structuring, and before that was a Private Equity Associate at Audax Private Equity and an Investment Banking Analyst at Jefferies. She holds a BA in Mathematics and Finance from Washington University in St. Louis.

Keegan Hasson joined Revelation Partners in 2023, where he supports the firm's sourcing and transaction execution work. He previously worked as an Associate in Goldman Sachs's Healthcare Investment Banking group, working on M&A, separations, and financing transactions. He holds a dual BS in Economics and Computer Science from Duke University.

Vicky Valverde joined Revelation Partners in 2024, where she works on transaction execution and diligence. She previously worked on the healthcare team at NEA, conducting diligence and supporting digital health portfolio companies, and began her career in investment banking at Goldman Sachs within its Healthcare Group focused on M&A advisory. She holds an MS in Bioinformatics and a BS in Bioengineering from Stanford University.